US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Acurx Pharmaceuticals, LLC*

0.5870

+0.03706.73%

Volume:1.69M

Turnover:961.52K

Market Cap:13.78M

PE:-0.86

High:0.6274

Open:0.5500

Low:0.5192

Close:0.5500

Loading ...

Overview Company News Filings

Acurx Pharmaceuticals Announces $2.67 Million Private Placement Through Warrant Exercise

Top Midday Gainers

MT Newswires Live

Why Is Acurx Pharmaceuticals Stock (ACXP) Up 250% Today?

Acurx Pharmaceuticals Announces Promising Phase 2b Clinical Trial Results for Ibezapolstat in Treating C. difficile Infection, Prepares for Phase 3 Trials

Acurx Announces Publication in Lancet Microbe of Phase 2B Clinical Trial Data for Ibezapolstat in Cdi

THOMSON REUTERS

BRIEF-Acurx Pharmaceuticals Announces Presentation Of Results From Leiden University Medical Center Public-Private Partnership For Its DNA pol IIIC Inhibitors

Acurx Pharmaceuticals Announces Advancement of Ibezapolstat to Phase 3 Clinical Trials for C. difficile Infection Treatment

Acurx Pharmaceuticals Announces Presentation of Results From Leiden University Medical Center Public-Private Partnership for Its DNA Pol Iiic Inhibitors at the Federation of American Societies for Experimental Biology Scientific Conference

THOMSON REUTERS

BRIEF-Acurx Pharmaceuticals Inc Files For Resale Of Up To 10.9 Million Shares Of Common Stock By The Selling Stockholder - SEC Filing

Acurx Pharmaceuticals Inc Files for Resale of up to 10.9 Mln Shares of Common Stock by the Selling Stockholder - SEC Filing

THOMSON REUTERS

H.C. Wainwright Resumes Coverage with a Buy Rating on Acurx Pharmaceuticals (ACXP)

Acurx Pharmaceuticals Inc reports results for the quarter ended March 31 - Earnings Summary

BRIEF-Acurx Pharmaceuticals Q1 Net Income USD -2.1 Million

Acurx Pharmaceuticals Q1 EPS $(0.11) Beats $(0.15) Estimate

Acurx Pharmaceuticals Secures New Patent from Japanese Patent Office for DNA Polymerase IIIC Inhibitors, Expanding Antibiotic Development Program

Acurx Pharmaceuticals, Inc. Reports First Quarter Results and Provides Business Update

THOMSON REUTERS

Press Release: Acurx Pharmaceuticals, Inc. Reports First Quarter Results and Provides Business Update

Acurx Pharmaceuticals Inc expected to post a loss of 15 cents a share - Earnings Preview

BRIEF-Acurx Pharmaceuticals To Discuss First Quarter 2025 Financial Results

Acurx Pharmaceuticals to Discuss First Quarter 2025 Financial Results on May 13, 2025 Conference Call and Provide Business Update

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/ACXP/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ACXP","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ACXP\",,,,,undefined,":{"symbol":"ACXP","market":"US","secType":"STK","nameCN":"Acurx Pharmaceuticals, LLC*","latestPrice":0.587,"timestamp":1750704891146,"preClose":0.55,"halted":0,"volume":1690163,"delay":0,"floatShares":20909500,"shares":23481606,"eps":-0.686187,"marketStatus":"Trading","change":0.037,"latestTime":"06-23 15:00:03 EDT","open":0.55,"high":0.6274,"low":0.5192,"amount":961516.9980863,"amplitude":0.196727,"askPrice":0.6088,"askSize":100,"bidPrice":0.59,"bidSize":900,"shortable":0,"etf":0,"ttmEps":-0.686187,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1750708800000},"marketStatusCode":2,"adr":0,"listingDate":1624593600000,"exchange":"NASDAQ","adjPreClose":0.55,"preHourTrading":{"tag":"盘前","latestPrice":0.531,"preClose":0.55,"latestTime":"09:29 EDT","volume":93265,"amount":49930.415685500004,"timestamp":1750685395608},"postHourTrading":{"tag":"盘后","latestPrice":0.591,"preClose":0.55,"latestTime":"19:59 EDT","volume":187448,"amount":106524.47539,"timestamp":1750463997415},"volumeRatio":0.027636,"impliedVol":0.4791,"impliedVolPercentile":0.196},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ACXP\",,,,,undefined,":{"symbol":"ACXP","floatShares":20909500,"roa":"-106.67%","roe":"-285.79%","lyrEps":-0.872535,"volumeRatio":0.027636,"shares":23481606,"dividePrice":0,"high":0.6274,"amplitude":0.196727,"preClose":0.55,"low":0.5192,"week52Low":0.3,"pbRate":"5.96","week52High":3.325,"institutionHeld":0,"latestPrice":0.587,"committee":0.8,"eps":-0.686187,"divideRate":0,"volume":1690163,"delay":0,"ttmEps":-0.686187,"open":0.55,"prevYearClose":0.814,"prevWeekClose":0.55,"prevMonthClose":0.3886,"prevQuarterClose":0.39,"fiveDayClose":0.305,"twentyDayClose":0.3982,"sixtyDayClose":0.435},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ACXP\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2544917042","title":"Acurx Pharmaceuticals Announces $2.67 Million Private Placement Through Warrant Exercise","url":"https://stock-news.laohu8.com/highlight/detail?id=2544917042","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2544917042?lang=en_us&edition=fundamental","pubTime":"2025-06-18 09:47","pubTimestamp":1750211264,"startTime":"0","endTime":"0","summary":"Acurx Pharmaceuticals Inc., a late-stage biopharmaceutical company specializing in developing a new class of antibiotics, has announced a warrant inducement agreement with a holder of existing warrants. This agreement involves the exercise of warrants to purchase up to 4,445,435 shares of common stock at a reduced exercise price of $0.675 per share, generating gross proceeds of approximately $2.67 million. In exchange for this exercise, the investors received G-1 and G-2 warrants to purchase up to 8,890,870 shares of common stock. The G-1 Warrants are immediately exercisable at an exercise price of $0.425 per share, while the G-2 Warrants will become exercisable upon shareholder approval. The company plans to use the net proceeds for working capital and general corporate purposes. The transaction is expected to close by June 20, 2025, pending customary closing conditions.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250618:nNDL7tNPDy:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","BK4139","ACXP","BK4563"],"gpt_icon":0},{"id":"2544399294","title":"Top Midday Gainers","url":"https://stock-news.laohu8.com/highlight/detail?id=2544399294","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2544399294?lang=en_us&edition=fundamental","pubTime":"2025-06-18 02:14","pubTimestamp":1750184079,"startTime":"0","endTime":"0","summary":"CERo Therapeutics  said Tuesday that the US Food and Drug Administration has granted orphan drug designation for its lead drug candidate, CER-1236, for acute myeloid leukemia.Shares jumped over 220% as intraday trading volume advanced to over 51.2 million from a daily average of about 101,000.Acurx Pharmaceuticals  said its lead antibiotic candidate, ibezapolstat, is ready to advance to international phase 3 clinical trials to treat patients with C. difficile infection.Shares soared over 130% as intraday trading volume surged to more than 309 million from a daily average of roughly 182,000.Eli Lilly  said that it agreed to acquire Verve Therapeutics  for up to about $1.3 billion to advance gene-editing therapies for cardiovascular disease.Verve shares soared 78%, with intraday trading volume of more than 72.5 million against a daily average of about 3.49 million.Price: 22.04, Change: +15.18, Percent Change: +220.97","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0320765992.SGD","LU0385154629.USD","LU2602419157.SGD","BK4588","LU0889565916.HKD","IE00BJT1NW94.SGD","LU1720051108.HKD","BK4516","IE0009355771.USD","LU0061475181.USD","LU0234572021.USD","LU0320765059.SGD","SG9999015986.USD","LU2361045086.USD","LU1366192091.USD","BK4007","LU2552382215.SGD","SG9999015945.SGD","LU0456855351.SGD","LU2468319806.SGD","LU2237438978.USD","SG9999014906.USD","SGXZ51526630.SGD","IE00BK4W5L77.USD","LU0058720904.USD","LU0097036916.USD","LU1291159041.SGD","SG9999018857.SGD","CERO","LU1232071149.USD","LU2237443978.SGD","LU0786609619.USD","ACXP","LU0354030511.USD","GB00BDT5M118.USD","LU0820561818.USD","LU2491050154.USD","LU2112291526.USD","LU1974910355.USD","LU0106261372.USD","BK4563","LU1093756168.USD","LU0417517546.SGD","LU1917777945.USD","SGXZ81514606.USD","LU0354030438.USD","LU1023059063.AUD","LU0471298777.SGD"],"gpt_icon":1},{"id":"2544962251","title":"Why Is Acurx Pharmaceuticals Stock (ACXP) Up 250% Today?","url":"https://stock-news.laohu8.com/highlight/detail?id=2544962251","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2544962251?lang=en_us&edition=fundamental","pubTime":"2025-06-17 20:16","pubTimestamp":1750162599,"startTime":"0","endTime":"0","summary":"Acurx Pharmaceuticals stock rocketed over 250% on Tuesday after it announced updated clinical trial data.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/why-is-acurx-pharmaceuticals-stock-acxp-up-250-today?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/why-is-acurx-pharmaceuticals-stock-acxp-up-250-today?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4563","BK4139","BK4539","ACXP"],"gpt_icon":0},{"id":"2544969297","title":"Acurx Pharmaceuticals Announces Promising Phase 2b Clinical Trial Results for Ibezapolstat in Treating C. difficile Infection, Prepares for Phase 3 Trials","url":"https://stock-news.laohu8.com/highlight/detail?id=2544969297","media":"Reuters","labels":["productRelease","dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2544969297?lang=en_us&edition=fundamental","pubTime":"2025-06-17 19:01","pubTimestamp":1750158092,"startTime":"0","endTime":"0","summary":"Acurx Pharmaceuticals Announces Promising Phase 2b Clinical Trial Results for Ibezapolstat in Treating C. difficile Infection, Prepares for Phase 3 Trials. Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Acurx Pharmaceuticals Inc. published the original content used to generate this news brief via PR Newswire  on June 17, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250617:nNDL7glx6j:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease,dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ACXP","BK4539","BK4563","BK4139"],"gpt_icon":0},{"id":"2544692569","title":"Acurx Announces Publication in Lancet Microbe of Phase 2B Clinical Trial Data for Ibezapolstat in Cdi","url":"https://stock-news.laohu8.com/highlight/detail?id=2544692569","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2544692569?lang=en_us&edition=fundamental","pubTime":"2025-06-17 19:01","pubTimestamp":1750158062,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250617:nTUA73RRVG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","BK4539","BK4563","ACXP"],"gpt_icon":0},{"id":"2542038455","title":"BRIEF-Acurx Pharmaceuticals Announces Presentation Of Results From Leiden University Medical Center Public-Private Partnership For Its DNA pol IIIC Inhibitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2542038455","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542038455?lang=en_us&edition=fundamental","pubTime":"2025-06-09 20:08","pubTimestamp":1749470938,"startTime":"0","endTime":"0","summary":"BRIEF-Acurx Pharmaceuticals Announces Presentation Of Results From Leiden University Medical Center Public-Private Partnership For Its DNA pol IIIC InhibitorsJune 9 (Reuters) - Acurx Pharmaceuticals I","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250609:nTUA2G7MCD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","BK4139","ACXP","BK4563"],"gpt_icon":0},{"id":"2542389791","title":"Acurx Pharmaceuticals Announces Advancement of Ibezapolstat to Phase 3 Clinical Trials for C. difficile Infection Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2542389791","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542389791?lang=en_us&edition=fundamental","pubTime":"2025-06-09 19:30","pubTimestamp":1749468643,"startTime":"0","endTime":"0","summary":"Acurx Pharmaceuticals Inc. has announced the advancement of its lead antibiotic candidate, ibezapolstat, to international pivotal Phase 3 clinical trials for the treatment of C. difficile infection . The company has been working in collaboration with Leiden University Medical Center  to study the mechanism of action of DNA pol IIIC inhibitors. Results from this collaboration were presented at a scientific conference on May 21 by Dr. Mia Urem from LUMC. These findings provide insight into the structural biology of DNA pol IIIC in complex with inhibitors, which is crucial for developing this new class of antibiotics aimed at treating resistant gram-positive infections. Acurx's Executive Chairman, Bob DeLuccia, emphasized the importance of these data in guiding the design of new compounds to combat antimicrobial resistance. Further details of the presentation are available on the company's website.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250609:nNDL3JvQsf:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","ACXP","BK4139","BK4563"],"gpt_icon":0},{"id":"2542779389","title":"Acurx Pharmaceuticals Announces Presentation of Results From Leiden University Medical Center Public-Private Partnership for Its DNA Pol Iiic Inhibitors at the Federation of American Societies for Experimental Biology Scientific Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2542779389","media":"THOMSON REUTERS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542779389?lang=en_us&edition=fundamental","pubTime":"2025-06-09 19:30","pubTimestamp":1749468604,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250609:nTUA2G7MCD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","BK4563","BK4539","ACXP"],"gpt_icon":0},{"id":"2537951348","title":"BRIEF-Acurx Pharmaceuticals Inc Files For Resale Of Up To 10.9 Million Shares Of Common Stock By The Selling Stockholder - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2537951348","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537951348?lang=en_us&edition=fundamental","pubTime":"2025-05-22 04:40","pubTimestamp":1747860008,"startTime":"0","endTime":"0","summary":"BRIEF-Acurx Pharmaceuticals Inc Files For Resale Of Up To 10.9 Million Shares Of Common Stock By The Selling Stockholder - SEC FilingAcurx Pharmaceuticals Inc ACXP.O:ACURX PHARMACEUTICALS INC FILES FOR RESALE OF UP TO 10.9 MILLION SHARES OF COMMON STOCK BY THE SELLING STOCKHOLDER - SEC FILINGSource text: [ID:n0001104659-25-051615]Further company coverage: ACXP.O","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250521:nFWN3RT2WG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4563","BK4539","BK4139","ACXP"],"gpt_icon":0},{"id":"2537959605","title":"Acurx Pharmaceuticals Inc Files for Resale of up to 10.9 Mln Shares of Common Stock by the Selling Stockholder - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2537959605","media":"THOMSON REUTERS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537959605?lang=en_us&edition=fundamental","pubTime":"2025-05-22 04:17","pubTimestamp":1747858639,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250521:nFWN3RT2WG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ACXP","BK4539","BK4139","BK4563"],"gpt_icon":0},{"id":"2536158020","title":"H.C. Wainwright Resumes Coverage with a Buy Rating on Acurx Pharmaceuticals (ACXP)","url":"https://stock-news.laohu8.com/highlight/detail?id=2536158020","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2536158020?lang=en_us&edition=fundamental","pubTime":"2025-05-18 01:37","pubTimestamp":1747503466,"startTime":"0","endTime":"0","summary":"In a report released on May 15, Matthew Keller from H.C. Wainwright resumed coverage with a Buy rating on Acurx Pharmaceuticals (ACXP – Research Re...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/h-c-wainwright-resumes-coverage-with-a-buy-rating-on-acurx-pharmaceuticals-acxp?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/h-c-wainwright-resumes-coverage-with-a-buy-rating-on-acurx-pharmaceuticals-acxp?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ACXP"],"gpt_icon":0},{"id":"2535779244","title":"Acurx Pharmaceuticals Inc reports results for the quarter ended March 31 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2535779244","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535779244?lang=en_us&edition=fundamental","pubTime":"2025-05-13 21:31","pubTimestamp":1747143103,"startTime":"0","endTime":"0","summary":"Acurx Pharmaceuticals Inc reports results for the quarter ended March 31 - Earnings SummaryAcurx Pharmaceuticals Inc ACXP.OQ reported a quarterly adjusted loss of 11 cents per share for the quarter en","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250513:nL8N3RL1KO:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ACXP"],"gpt_icon":0},{"id":"2535724602","title":"BRIEF-Acurx Pharmaceuticals Q1 Net Income USD -2.1 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2535724602","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535724602?lang=en_us&edition=fundamental","pubTime":"2025-05-13 19:40","pubTimestamp":1747136447,"startTime":"0","endTime":"0","summary":"BRIEF-Acurx Pharmaceuticals Q1 Net Income USD -2.1 MillionMay 13 (Reuters) - Acurx Pharmaceuticals Inc ACXP.O:ACURX PHARMACEUTICALS Q1 NET INCOME USD -2.1 MILLIONSource text: ID:nPn75ZGfmaFurther company coverage: ACXP.O ((Reuters.Briefs@thomsonreuters.com;))","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250513:nPLXB34E92:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4563","BK4539","ACXP","BK4139"],"gpt_icon":0},{"id":"2535882726","title":"Acurx Pharmaceuticals Q1 EPS $(0.11) Beats $(0.15) Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2535882726","media":"Benzinga","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535882726?lang=en_us&edition=fundamental","pubTime":"2025-05-13 19:03","pubTimestamp":1747134187,"startTime":"0","endTime":"0","summary":"Acurx Pharmaceuticals Q1 EPS $(0.11) Beats $(0.15) Estimate","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/05/45371284/acurx-pharmaceuticals-q1-eps-0-11-beats-0-15-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ACXP"],"gpt_icon":0},{"id":"2535146725","title":"Acurx Pharmaceuticals Secures New Patent from Japanese Patent Office for DNA Polymerase IIIC Inhibitors, Expanding Antibiotic Development Program","url":"https://stock-news.laohu8.com/highlight/detail?id=2535146725","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535146725?lang=en_us&edition=fundamental","pubTime":"2025-05-13 19:01","pubTimestamp":1747134103,"startTime":"0","endTime":"0","summary":"Acurx Pharmaceuticals Secures New Patent from Japanese Patent Office for DNA Polymerase IIIC Inhibitors, Expanding Antibiotic Development Program. Acurx Pharmaceuticals has been granted a new patent by the Japanese Patent Office for its DNA polymerase IIIC inhibitors, which target the treatment of MRSA, VRE, and Anthrax infections. This patent is set to expire in December 2039, subject to extension, and represents a significant advancement in the ongoing development of their pre-clinical antibiotic candidate, ACX-375C.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Acurx Pharmaceuticals Inc. published the original content used to generate this news brief via PR Newswire  on May 13, 2025, and is solely responsible for the information co","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250513:nNDL1s0hyS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4539","BK4563","ACXP"],"gpt_icon":0},{"id":"2535725133","title":"Acurx Pharmaceuticals, Inc. Reports First Quarter Results and Provides Business Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2535725133","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535725133?lang=en_us&edition=fundamental","pubTime":"2025-05-13 19:01","pubTimestamp":1747134063,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250513:nTUA9PVHNW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4563","BK4539","ACXP","BK4139"],"gpt_icon":0},{"id":"2535567726","title":"Press Release: Acurx Pharmaceuticals, Inc. Reports First Quarter Results and Provides Business Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2535567726","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535567726?lang=en_us&edition=fundamental","pubTime":"2025-05-13 19:01","pubTimestamp":1747134060,"startTime":"0","endTime":"0","summary":"STATEN ISLAND, N.Y., May 13, 2025 /PRNewswire/ -- Acurx Pharmaceuticals, Inc.  , a late-stage biopharmaceutical company developing a new class of antibiotics for difficult-to-treat bacterial infections, announced today certain financial and operational results for the first quarter ended March 31, 2025.Highlights of the first quarter ended March 31, 2025, or in some cases shortly thereafter, include:. -- In January 2025, the Company announced it had closed a $2.5 million. registered direct offering priced at the market under Nasdaq rules.-- Also in January 2025, we announced that we received positive regulatory. guidance from the European Medicines Agency  for the ibezapolstat.  Phase 3 clinical trial program, which is aligned with FDA on. matters of manufacturing, non-clinical and clinical aspects of the Phase. 3 program. The EMA guidance also confirmed ibezapolstat's regulatory. pathway for a Marketing Authorization Application to be filed by the. Company after successful completion ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1989771016.USD","MET","LU0310800965.SGD","LU0048573561.USD","BK4194","LU1989772840.SGD","BK4022","LU1267930227.SGD","BK4202","LU0128525689.USD","LU1571399168.USD","LU0251142724.SGD","LU1496350502.SGD","BK4588","BK4162","BK4131","VRE","BK4232","NCI","BK4139","LU1291159041.SGD","LU0251131958.USD","LU0742534661.SGD","BK4585","BK4563","R","BK4533","BK4539","FDX","LU0052756011.USD","LU1989772923.USD","GAIN","BK4135","ACXP"],"gpt_icon":0},{"id":"2534317404","title":"Acurx Pharmaceuticals Inc  expected to post a loss of 15 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2534317404","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2534317404?lang=en_us&edition=fundamental","pubTime":"2025-05-09 23:24","pubTimestamp":1746804250,"startTime":"0","endTime":"0","summary":"Acurx Pharmaceuticals Inc  expected to post a loss of15cents a share - Earnings Preview Acurx Pharmaceuticals Inc ACXP.OQ ACXP.O is expected to show no change in quarterly revenue when it reports  res","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250509:nL8N3RH2H2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ACXP"],"gpt_icon":0},{"id":"2531034014","title":"BRIEF-Acurx Pharmaceuticals To Discuss First Quarter 2025 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2531034014","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531034014?lang=en_us&edition=fundamental","pubTime":"2025-04-30 20:41","pubTimestamp":1746016883,"startTime":"0","endTime":"0","summary":"BRIEF-Acurx Pharmaceuticals To Discuss First Quarter 2025 Financial Results April 30 (Reuters) - Acurx Pharmaceuticals Inc ACXP.O:ACURX PHARMACEUTICALS TO DISCUSS FIRST QUARTER 2025 FINANCIAL RESULTS ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250430:nTUA1QCYYB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4539","BK4563","ACXP"],"gpt_icon":0},{"id":"2531503566","title":"Acurx Pharmaceuticals to Discuss First Quarter 2025 Financial Results on May 13, 2025 Conference Call and Provide Business Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2531503566","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531503566?lang=en_us&edition=fundamental","pubTime":"2025-04-30 19:30","pubTimestamp":1746012603,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250430:nTUA1QCYYB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","ACXP","BK4539","BK4563"],"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":1,"totalSize":58,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ACXP\",params:#limit:5,,,undefined,":[{"date":"2025-05-13","symbol":"ACXP","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":"2025/03","expectedEps":-0.14,"defaultRemindTime":1747123200000,"name":null,"time":"Pre-Market","dateTimestamp":1747108800000,"actualEps":null},{"market":"US","date":"2025-03-18","symbol":"ACXP","fiscalQuarterEnding":"2024/12","expectedEps":-0.18,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1742270400000,"reportTimeType":"pre","actualEps":-0.38},{"date":"2024-11-13","symbol":"ACXP","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":"2024/09","expectedEps":-0.23,"defaultRemindTime":1731488400000,"name":null,"time":"Pre-Market","dateTimestamp":1731474000000,"actualEps":null},{"market":"US","date":"2024-08-09","symbol":"ACXP","fiscalQuarterEnding":"2024/06","expectedEps":-0.28,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1723176000000,"reportTimeType":"pre","actualEps":-0.26},{"date":"2024-05-15","symbol":"ACXP","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":"2024/03","expectedEps":-0.24,"defaultRemindTime":1715760000000,"name":null,"time":"Pre-Market","dateTimestamp":1715745600000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ACXP\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ACXP\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":3,"updateTime":1742356800000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/ACXP\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"ACXP","date":"2025-06-20","current":-1.423798,"percent":0.854855,"low":-15.698763,"twenty":-4.00415,"median":-2.862255,"eighty":-1.845009,"high":-0.470005,"avg":-3.215265,"sd":2.2535,"marketCap":16906756},"quantilePoints":[{"date":"2021-06-11","current":-11.938223,"twenty":-11.938223,"median":-11.938223,"eighty":-11.938223,"marketCap":57246954},{"date":"2021-06-15","current":-11.938223,"twenty":-11.938223,"median":-11.938223,"eighty":-11.938223,"marketCap":57246954},{"date":"2021-06-25","current":-15.698763,"twenty":-11.938223,"median":-11.938223,"eighty":-11.938223,"marketCap":75279744},{"date":"2021-07-02","current":-12.09725,"twenty":-12.878918,"median":-11.938223,"eighty":-11.938223,"marketCap":58009530},{"date":"2021-07-09","current":-12.572868,"twenty":-12.738301,"median":-11.938223,"eighty":-11.938223,"marketCap":60290246},{"date":"2021-07-16","current":-12.469473,"twenty":-12.639041,"median":-12.076571,"eighty":-11.938223,"marketCap":59794438},{"date":"2021-07-23","current":-11.518236,"twenty":-12.560461,"median":-12.014533,"eighty":-11.866925,"marketCap":55233005},{"date":"2021-07-30","current":-11.745706,"twenty":-12.502559,"median":-11.938223,"eighty":-11.580273,"marketCap":56323783},{"date":"2021-08-06","current":-10.050023,"twenty":-12.458729,"median":-11.938223,"eighty":-11.427248,"marketCap":48192532},{"date":"2021-08-13","current":-6.159321,"twenty":-12.399613,"median":-11.893662,"eighty":-10.608357,"marketCap":48572198},{"date":"2021-08-20","current":-5.607549,"twenty":-12.287497,"median":-11.828422,"eighty":-10.06243,"marketCap":44220938},{"date":"2021-08-27","current":-6.172153,"twenty":-12.088978,"median":-11.528575,"eighty":-7.064488,"marketCap":48673390},{"date":"2021-09-03","current":-7.416849,"twenty":-12.051755,"median":-11.476878,"eighty":-6.405694,"marketCap":58489022},{"date":"2021-09-10","current":-6.41596,"twenty":-12.035212,"median":-10.897864,"eighty":-6.364632,"marketCap":50596040},{"date":"2021-09-17","current":-5.877019,"twenty":-12.014533,"median":-10.608357,"eighty":-6.364632,"marketCap":46345972},{"date":"2021-09-24","current":-5.626797,"twenty":-11.938223,"median":-10.215455,"eighty":-6.172153,"marketCap":44372727},{"date":"2021-10-01","current":-6.68543,"twenty":-11.938223,"median":-9.998325,"eighty":-6.159321,"marketCap":52721073},{"date":"2021-10-08","current":-5.248255,"twenty":-11.938223,"median":-9.863911,"eighty":-5.992506,"marketCap":41387560},{"date":"2021-10-15","current":-6.300472,"twenty":-11.938223,"median":-7.333442,"eighty":-5.979674,"marketCap":49685311},{"date":"2021-10-22","current":-6.184985,"twenty":-11.938223,"median":-6.865077,"eighty":-5.979674,"marketCap":48774582},{"date":"2021-10-29","current":-6.41596,"twenty":-11.938223,"median":-6.794501,"eighty":-5.992506,"marketCap":50596040},{"date":"2021-11-05","current":-6.852245,"twenty":-11.938223,"median":-6.865077,"eighty":-6.031002,"marketCap":54036570},{"date":"2021-11-12","current":-4.527743,"twenty":-11.849101,"median":-6.858661,"eighty":-6.031002,"marketCap":50772486},{"date":"2021-11-19","current":-4.427531,"twenty":-11.828422,"median":-6.736758,"eighty":-5.966842,"marketCap":49648749},{"date":"2021-11-26","current":-4.454861,"twenty":-11.828422,"median":-6.68543,"eighty":-5.861621,"marketCap":49955222},{"date":"2021-12-03","current":-3.780711,"twenty":-11.762249,"median":-6.614854,"eighty":-5.699938,"marketCap":42395536},{"date":"2021-12-10","current":-3.835372,"twenty":-11.580273,"median":-6.557111,"eighty":-5.569053,"marketCap":43008484},{"date":"2021-12-17","current":-4.035795,"twenty":-11.522372,"median":-6.505783,"eighty":-5.166131,"marketCap":45255958},{"date":"2021-12-23","current":-4.32732,"twenty":-11.493421,"median":-6.428792,"eighty":-4.527743,"marketCap":48525012},{"date":"2021-12-31","current":-3.936859,"twenty":-11.476878,"median":-6.41596,"eighty":-4.409311,"marketCap":44146523},{"date":"2022-01-07","current":-4.017574,"twenty":-11.439656,"median":-6.358216,"eighty":-4.32732,"marketCap":45051642},{"date":"2022-01-14","current":-4.172447,"twenty":-11.104655,"median":-6.313304,"eighty":-4.289057,"marketCap":46788327},{"date":"2022-01-21","current":-3.316093,"twenty":-10.839963,"median":-6.223481,"eighty":-4.21982,"marketCap":37185482},{"date":"2022-01-28","current":-3.534737,"twenty":-10.695209,"median":-6.172153,"eighty":-4.137828,"marketCap":39637272},{"date":"2022-02-04","current":-3.589398,"twenty":-10.608357,"median":-6.159321,"eighty":-4.074057,"marketCap":40250220},{"date":"2022-02-11","current":-3.71694,"twenty":-10.550456,"median":-6.063082,"eighty":-4.024862,"marketCap":41680431},{"date":"2022-02-18","current":-3.73516,"twenty":-10.364344,"median":-5.979674,"eighty":-3.984778,"marketCap":41884747},{"date":"2022-02-25","current":-3.252322,"twenty":-10.194776,"median":-5.966842,"eighty":-3.953804,"marketCap":36470377},{"date":"2022-03-04","current":-3.252322,"twenty":-10.099653,"median":-5.896267,"eighty":-3.859058,"marketCap":36470377},{"date":"2022-03-11","current":-3.644059,"twenty":-10.029344,"median":-5.787196,"eighty":-3.791643,"marketCap":40863168},{"date":"2022-03-18","current":-2.922007,"twenty":-9.942491,"median":-5.68454,"eighty":-3.755202,"marketCap":37248855},{"date":"2022-03-25","current":-2.838922,"twenty":-9.913541,"median":-5.607549,"eighty":-3.720584,"marketCap":36189718},{"date":"2022-04-01","current":-2.737374,"twenty":-9.379631,"median":-5.44715,"eighty":-3.682321,"marketCap":34895218},{"date":"2022-04-08","current":-2.881869,"twenty":-7.43738,"median":-5.248255,"eighty":-3.645881,"marketCap":36737195},{"date":"2022-04-14","current":-3.210996,"twenty":-7.416849,"median":-4.609734,"eighty":-3.634948,"marketCap":40932808},{"date":"2022-04-22","current":-3.210996,"twenty":-7.250034,"median":-4.504968,"eighty":-3.534737,"marketCap":40932808},{"date":"2022-04-29","current":-3.003032,"twenty":-7.237203,"median":-4.427531,"eighty":-3.388974,"marketCap":38281743},{"date":"2022-05-06","current":-3.123797,"twenty":-7.121715,"median":-4.35465,"eighty":-3.315273,"marketCap":39821223},{"date":"2022-05-13","current":-1.994712,"twenty":-7.044724,"median":-4.32732,"eighty":-3.252322,"marketCap":27813277},{"date":"2022-05-20","current":-1.943188,"twenty":-7.01906,"median":-4.318209,"eighty":-3.210996,"marketCap":27094853},{"date":"2022-05-27","current":-1.923388,"twenty":-6.993396,"median":-4.236218,"eighty":-3.146776,"marketCap":26818773},{"date":"2022-06-03","current":-1.880623,"twenty":-6.942068,"median":-4.208888,"eighty":-3.079156,"marketCap":26222481},{"date":"2022-06-10","current":-2.774931,"twenty":-6.918971,"median":-4.158782,"eighty":-3.024918,"marketCap":38692271},{"date":"2022-06-17","current":-2.679244,"twenty":-6.906139,"median":-4.117786,"eighty":-2.999671,"marketCap":37358055},{"date":"2022-06-24","current":-2.716047,"twenty":-6.880475,"median":-4.090456,"eighty":-2.939922,"marketCap":37871215},{"date":"2022-07-01","current":-2.76021,"twenty":-6.857378,"median":-4.044905,"eighty":-2.90143,"marketCap":38487007},{"date":"2022-07-08","current":-2.760137,"twenty":-6.852245,"median":-4.026684,"eighty":-2.848154,"marketCap":38485981},{"date":"2022-07-15","current":-2.668203,"twenty":-6.80605,"median":-4.008464,"eighty":-2.820986,"marketCap":37204107},{"date":"2022-07-22","current":-2.657162,"twenty":-6.72136,"median":-3.972024,"eighty":-2.802901,"marketCap":37050159},{"date":"2022-07-29","current":-2.635081,"twenty":-6.693129,"median":-3.953804,"eighty":-2.779424,"marketCap":36742263},{"date":"2022-08-05","current":-2.88534,"twenty":-6.68543,"median":-3.921918,"eighty":-2.779424,"marketCap":40231751},{"date":"2022-08-12","current":-3.956018,"twenty":-6.664899,"median":-3.844482,"eighty":-2.782292,"marketCap":49687496},{"date":"2022-08-19","current":-3.519492,"twenty":-6.618704,"median":-3.839927,"eighty":-2.785236,"marketCap":44204738},{"date":"2022-08-26","current":-3.110248,"twenty":-6.585341,"median":-3.798931,"eighty":-2.789652,"marketCap":39064652},{"date":"2022-09-02","current":-3.073871,"twenty":-6.56481,"median":-3.780666,"eighty":-2.792596,"marketCap":38607755},{"date":"2022-09-09","current":-3.965112,"twenty":-6.551978,"median":-3.772829,"eighty":-2.798485,"marketCap":49801720},{"date":"2022-09-16","current":-3.542438,"twenty":-6.531447,"median":-3.78062,"eighty":-2.805846,"marketCap":44492944},{"date":"2022-09-23","current":-2.787945,"twenty":-6.521181,"median":-3.757935,"eighty":-2.805846,"marketCap":35016525},{"date":"2022-09-30","current":-2.760341,"twenty":-6.47242,"median":-3.73516,"eighty":-2.805846,"marketCap":34669827},{"date":"2022-10-07","current":-3.128387,"twenty":-6.436491,"median":-3.71694,"eighty":-2.811734,"marketCap":39292470},{"date":"2022-10-14","current":-2.714336,"twenty":-6.41596,"median":-3.689609,"eighty":-2.811734,"marketCap":34091996},{"date":"2022-10-21","current":-2.806347,"twenty":-6.41596,"median":-3.672742,"eighty":-2.791124,"marketCap":35247657},{"date":"2022-10-28","current":-3.027174,"twenty":-6.413394,"median":-3.653169,"eighty":-2.791124,"marketCap":38021243},{"date":"2022-11-04","current":-2.723537,"twenty":-6.395429,"median":-3.644059,"eighty":-2.783423,"marketCap":34207562},{"date":"2022-11-11","current":-2.94384,"twenty":-6.362066,"median":-3.619529,"eighty":-2.778468,"marketCap":33734492},{"date":"2022-11-18","current":-3.196747,"twenty":-6.346667,"median":-3.595377,"eighty":-2.782292,"marketCap":36632644},{"date":"2022-11-25","current":-2.953956,"twenty":-6.326136,"median":-3.588921,"eighty":-2.782292,"marketCap":33850418},{"date":"2022-12-02","current":-3.338375,"twenty":-6.313304,"median":-3.534737,"eighty":-2.787945,"marketCap":38255609},{"date":"2022-12-09","current":-3.743026,"twenty":-6.300472,"median":-3.538588,"eighty":-2.789652,"marketCap":42892653},{"date":"2022-12-16","current":-3.874538,"twenty":-6.223481,"median":-3.589398,"eighty":-2.789652,"marketCap":44399692},{"date":"2022-12-23","current":-3.975701,"twenty":-6.184985,"median":-3.603063,"eighty":-2.797013,"marketCap":45558953},{"date":"2022-12-30","current":-4.026282,"twenty":-6.174719,"median":-3.62058,"eighty":-2.802902,"marketCap":46138583},{"date":"2023-01-06","current":-4.501748,"twenty":-6.172153,"median":-3.638406,"eighty":-2.805558,"marketCap":51587110},{"date":"2023-01-13","current":-4.299422,"twenty":-6.164454,"median":-3.644059,"eighty":-2.809579,"marketCap":49268588},{"date":"2023-01-20","current":-4.258957,"twenty":-6.159321,"median":-3.653169,"eighty":-2.811734,"marketCap":48804883},{"date":"2023-01-27","current":-3.884654,"twenty":-6.149055,"median":-3.672742,"eighty":-2.8141,"marketCap":44515618},{"date":"2023-02-03","current":-3.540701,"twenty":-6.118259,"median":-3.662279,"eighty":-2.817733,"marketCap":40574131},{"date":"2023-02-10","current":-3.540701,"twenty":-6.069498,"median":-3.644059,"eighty":-2.819825,"marketCap":40574131},{"date":"2023-02-17","current":-3.70246,"twenty":-6.015604,"median":-3.644059,"eighty":-2.823936,"marketCap":42427789},{"date":"2023-02-24","current":-3.287793,"twenty":-5.98994,"median":-3.641863,"eighty":-2.825677,"marketCap":37675979},{"date":"2023-03-03","current":-3.641863,"twenty":-5.979674,"median":-3.638406,"eighty":-2.827332,"marketCap":41733392},{"date":"2023-03-10","current":-3.469887,"twenty":-5.977108,"median":-3.621631,"eighty":-2.83395,"marketCap":39762648},{"date":"2023-03-17","current":-3.021341,"twenty":-5.959143,"median":-3.604508,"eighty":-2.834944,"marketCap":36536396},{"date":"2023-03-24","current":-3.406225,"twenty":-5.925781,"median":-3.592246,"eighty":-2.839484,"marketCap":41190714},{"date":"2023-03-31","current":-3.329248,"twenty":-5.907816,"median":-3.59034,"eighty":-2.843856,"marketCap":40259850},{"date":"2023-04-06","current":-3.396603,"twenty":-5.877019,"median":-3.579746,"eighty":-2.852353,"marketCap":41074356},{"date":"2023-04-14","current":-2.751922,"twenty":-5.800028,"median":-3.550817,"eighty":-2.852353,"marketCap":33278373},{"date":"2023-04-21","current":-2.97323,"twenty":-5.787196,"median":-3.550817,"eighty":-2.848143,"marketCap":35954606},{"date":"2023-04-28","current":-2.866607,"twenty":-5.735868,"median":-3.540701,"eighty":-2.852353,"marketCap":34665231},{"date":"2023-05-05","current":-2.827999,"twenty":-5.710204,"median":-3.534737,"eighty":-2.841732,"marketCap":34198359},{"date":"2023-05-12","current":-3.19477,"twenty":-5.669142,"median":-3.525038,"eighty":-2.846189,"marketCap":38633641},{"date":"2023-05-19","current":-2.850337,"twenty":-5.633213,"median":-3.510352,"eighty":-2.847975,"marketCap":35132102},{"date":"2023-05-26","current":-2.937567,"twenty":-5.611399,"median":-3.474945,"eighty":-2.849898,"marketCap":36207255},{"date":"2023-06-02","current":-2.937567,"twenty":-5.59985,"median":-3.447184,"eighty":-2.851547,"marketCap":36207255},{"date":"2023-06-09","current":-2.808114,"twenty":-5.517726,"median":-3.439538,"eighty":-2.851547,"marketCap":34611681},{"date":"2023-06-16","current":-2.738409,"twenty":-5.4433,"median":-3.429421,"eighty":-2.847807,"marketCap":33752526},{"date":"2023-06-23","current":-2.569126,"twenty":-5.402238,"median":-3.402649,"eighty":-2.838681,"marketCap":31666006},{"date":"2023-06-30","current":-2.68862,"twenty":-5.340645,"median":-3.397344,"eighty":-2.829189,"marketCap":33138844},{"date":"2023-07-07","current":-2.540461,"twenty":-5.248255,"median":-3.388974,"eighty":-2.822775,"marketCap":31312689},{"date":"2023-07-14","current":-2.40399,"twenty":-4.837634,"median":-3.364889,"eighty":-2.811734,"marketCap":29630603},{"date":"2023-07-21","current":-2.361999,"twenty":-4.609734,"median":-3.350513,"eighty":-2.798157,"marketCap":29113038},{"date":"2023-07-28","current":-1.847608,"twenty":-4.542213,"median":-3.33875,"eighty":-2.787945,"marketCap":22772865},{"date":"2023-08-04","current":-2.21503,"twenty":-4.527743,"median":-3.338375,"eighty":-2.777512,"marketCap":27301560},{"date":"2023-08-11","current":-1.900097,"twenty":-4.527743,"median":-3.329248,"eighty":-2.760341,"marketCap":23419821},{"date":"2023-08-18","current":-1.869135,"twenty":-4.501748,"median":-3.318884,"eighty":-2.76021,"marketCap":24579691},{"date":"2023-08-25","current":-2.017479,"twenty":-4.482192,"median":-3.315273,"eighty":-2.741939,"marketCap":26530461},{"date":"2023-09-01","current":-1.908693,"twenty":-4.454861,"median":-3.304204,"eighty":-2.73148,"marketCap":25099897},{"date":"2023-09-08","current":-1.75046,"twenty":-4.432997,"median":-3.297891,"eighty":-2.723392,"marketCap":23019076},{"date":"2023-09-15","current":-1.710901,"twenty":-4.39109,"median":-3.28304,"eighty":-2.713206,"marketCap":22498871},{"date":"2023-09-22","current":-1.582336,"twenty":-4.374692,"median":-3.266474,"eighty":-2.696583,"marketCap":20808204},{"date":"2023-09-29","current":-1.463661,"twenty":-4.343718,"median":-3.252322,"eighty":-2.679128,"marketCap":19247589},{"date":"2023-10-06","current":-1.542778,"twenty":-4.329142,"median":-3.235119,"eighty":-2.671147,"marketCap":20287999},{"date":"2023-10-13","current":-4.034958,"twenty":-4.32732,"median":-3.237569,"eighty":-2.671147,"marketCap":53060922},{"date":"2023-10-20","current":-4.964581,"twenty":-4.374692,"median":-3.256877,"eighty":-2.671883,"marketCap":65285742},{"date":"2023-10-27","current":-4.667893,"twenty":-4.397094,"median":-3.266474,"eighty":-2.673013,"marketCap":61384204},{"date":"2023-11-03","current":-3.758049,"twenty":-4.476726,"median":-3.28304,"eighty":-2.677757,"marketCap":49419486},{"date":"2023-11-10","current":-3.708601,"twenty":-4.449395,"median":-3.283194,"eighty":-2.678778,"marketCap":48769230},{"date":"2023-11-17","current":-3.917109,"twenty":-4.422199,"median":-3.297873,"eighty":-2.680716,"marketCap":49840076},{"date":"2023-11-24","current":-4.187628,"twenty":-4.400873,"median":-3.300382,"eighty":-2.686605,"marketCap":53282070},{"date":"2023-12-01","current":-3.808902,"twenty":-4.38198,"median":-3.312639,"eighty":-2.68862,"marketCap":48463279},{"date":"2023-12-08","current":-4.696202,"twenty":-4.38198,"median":-3.318142,"eighty":-2.693965,"marketCap":59753020},{"date":"2023-12-15","current":-3.63577,"twenty":-4.37287,"median":-3.328111,"eighty":-2.697237,"marketCap":46260402},{"date":"2023-12-22","current":-3.884647,"twenty":-4.343718,"median":-3.333812,"eighty":-2.703555,"marketCap":49427037},{"date":"2023-12-29","current":-4.295835,"twenty":-4.333177,"median":-3.338375,"eighty":-2.706495,"marketCap":54658868},{"date":"2024-01-05","current":-4.285014,"twenty":-4.33643,"median":-3.338563,"eighty":-2.708536,"marketCap":54521188},{"date":"2024-01-12","current":-5.204777,"twenty":-4.400873,"median":-3.348492,"eighty":-2.708686,"marketCap":66223969},{"date":"2024-01-19","current":-4.328297,"twenty":-4.440176,"median":-3.358415,"eighty":-2.713206,"marketCap":55071908},{"date":"2024-01-26","current":-4.317476,"twenty":-4.429326,"median":-3.377159,"eighty":-2.715705,"marketCap":54934228},{"date":"2024-02-02","current":-3.527562,"twenty":-4.406205,"median":-3.396603,"eighty":-2.721877,"marketCap":44883605},{"date":"2024-02-09","current":-3.321968,"twenty":-4.385759,"median":-3.397158,"eighty":-2.723334,"marketCap":42267689},{"date":"2024-02-16","current":-3.300327,"twenty":-4.374692,"median":-3.388974,"eighty":-2.723392,"marketCap":41992329},{"date":"2024-02-23","current":-3.386893,"twenty":-4.359111,"median":-3.386893,"eighty":-2.723485,"marketCap":43093768},{"date":"2024-03-01","current":-3.105553,"twenty":-4.341834,"median":-3.386893,"eighty":-2.727023,"marketCap":39514093},{"date":"2024-03-08","current":-3.213761,"twenty":-4.33155,"median":-3.364889,"eighty":-2.730627,"marketCap":40890891},{"date":"2024-03-15","current":-2.932421,"twenty":-4.328297,"median":-3.350513,"eighty":-2.735016,"marketCap":37311217},{"date":"2024-03-22","current":-2.226653,"twenty":-4.328297,"median":-3.33875,"eighty":-2.723485,"marketCap":32459630},{"date":"2024-03-28","current":-2.518496,"twenty":-4.327906,"median":-3.338375,"eighty":-2.718962,"marketCap":36714047},{"date":"2024-04-05","current":-2.118563,"twenty":-4.32732,"median":-3.329248,"eighty":-2.706495,"marketCap":30883919},{"date":"2024-04-12","current":-2.021282,"twenty":-4.323676,"median":-3.321968,"eighty":-2.687411,"marketCap":29465780},{"date":"2024-04-19","current":-2.302316,"twenty":-4.318209,"median":-3.318884,"eighty":-2.674142,"marketCap":33562627},{"date":"2024-04-26","current":-2.183417,"twenty":-4.318209,"median":-3.315273,"eighty":-2.664523,"marketCap":31829346},{"date":"2024-05-03","current":-2.301105,"twenty":-4.317916,"median":-3.304204,"eighty":-2.652746,"marketCap":33544976},{"date":"2024-05-10","current":-2.192562,"twenty":-4.316324,"median":-3.29791,"eighty":-2.63511,"marketCap":31962666},{"date":"2024-05-17","current":-2.129106,"twenty":-4.308527,"median":-3.285571,"eighty":-2.616729,"marketCap":34177900},{"date":"2024-05-24","current":-2.57267,"twenty":-4.299422,"median":-3.281137,"eighty":-2.577025,"marketCap":41298296},{"date":"2024-05-31","current":-2.477227,"twenty":-4.298705,"median":-3.261432,"eighty":-2.56885,"marketCap":39766186},{"date":"2024-06-07","current":-2.368663,"twenty":-4.295086,"median":-3.249273,"eighty":-2.539607,"marketCap":38023444},{"date":"2024-06-14","current":-2.398272,"twenty":-4.291572,"median":-3.237569,"eighty":-2.530033,"marketCap":38498737},{"date":"2024-06-21","current":-2.299577,"twenty":-4.289508,"median":-3.235402,"eighty":-2.519465,"marketCap":36914427},{"date":"2024-06-28","current":-2.220622,"twenty":-4.285014,"median":-3.234651,"eighty":-2.502591,"marketCap":35646979},{"date":"2024-07-05","current":-2.033103,"twenty":-4.280355,"median":-3.233027,"eighty":-2.482891,"marketCap":32636790},{"date":"2024-07-12","current":-2.279839,"twenty":-4.271096,"median":-3.223405,"eighty":-2.467358,"marketCap":36597565},{"date":"2024-07-19","current":-2.398272,"twenty":-4.264513,"median":-3.212378,"eighty":-2.463479,"marketCap":38498737},{"date":"2024-07-26","current":-2.25023,"twenty":-4.25984,"median":-3.210996,"eighty":-2.445645,"marketCap":36122272},{"date":"2024-08-02","current":-2.08245,"twenty":-4.250864,"median":-3.208522,"eighty":-2.402846,"marketCap":33428945},{"date":"2024-08-09","current":-1.825588,"twenty":-4.246031,"median":-3.202969,"eighty":-2.384084,"marketCap":30540786},{"date":"2024-08-16","current":-1.951826,"twenty":-4.23804,"median":-3.197661,"eighty":-2.361358,"marketCap":32652648},{"date":"2024-08-23","current":-2.204301,"twenty":-4.236218,"median":-3.19477,"eighty":-2.345346,"marketCap":36876374},{"date":"2024-08-30","current":-2.136326,"twenty":-4.223316,"median":-3.188517,"eighty":-2.302074,"marketCap":35739217},{"date":"2024-09-06","current":-1.922694,"twenty":-4.219131,"median":-3.172148,"eighty":-2.286104,"marketCap":32165296},{"date":"2024-09-13","current":-1.980957,"twenty":-4.218492,"median":-3.165041,"eighty":-2.275891,"marketCap":33140001},{"date":"2024-09-20","current":-1.951826,"twenty":-4.21273,"median":-3.15797,"eighty":-2.265537,"marketCap":32652648},{"date":"2024-09-27","current":-1.86443,"twenty":-4.202511,"median":-3.146776,"eighty":-2.257421,"marketCap":31190590},{"date":"2024-10-04","current":-2.087774,"twenty":-4.19188,"median":-3.130117,"eighty":-2.249446,"marketCap":34926962},{"date":"2024-10-11","current":-2.010089,"twenty":-4.187628,"median":-3.128387,"eighty":-2.234788,"marketCap":33627354},{"date":"2024-10-18","current":-1.951826,"twenty":-4.187628,"median":-3.113033,"eighty":-2.220622,"marketCap":32652648},{"date":"2024-10-25","current":-1.786746,"twenty":-4.178519,"median":-3.10794,"eighty":-2.213319,"marketCap":29890982},{"date":"2024-11-01","current":-1.806167,"twenty":-4.166981,"median":-3.100143,"eighty":-2.203947,"marketCap":30215884},{"date":"2024-11-08","current":-1.806167,"twenty":-4.157871,"median":-3.088695,"eighty":-2.19356,"marketCap":30215884},{"date":"2024-11-15","current":-1.767787,"twenty":-4.150298,"median":-3.081142,"eighty":-2.181144,"marketCap":29055182},{"date":"2024-11-22","current":-1.387508,"twenty":-4.135209,"median":-3.07318,"eighty":-2.149641,"marketCap":22804939},{"date":"2024-11-29","current":-1.284729,"twenty":-4.125219,"median":-3.065235,"eighty":-2.140727,"marketCap":21115685},{"date":"2024-12-06","current":-0.770838,"twenty":-4.120736,"median":-3.05063,"eighty":-2.136326,"marketCap":12669411},{"date":"2024-12-13","current":-0.878858,"twenty":-4.111282,"median":-3.042419,"eighty":-2.129883,"marketCap":14444817},{"date":"2024-12-20","current":-0.847921,"twenty":-4.10134,"median":-3.035027,"eighty":-2.112058,"marketCap":13936352},{"date":"2024-12-27","current":-0.918838,"twenty":-4.100763,"median":-3.029808,"eighty":-2.097994,"marketCap":15101937},{"date":"2025-01-03","current":-0.914624,"twenty":-4.099566,"median":-3.026769,"eighty":-2.087774,"marketCap":15032678},{"date":"2025-01-10","current":-0.830655,"twenty":-4.092278,"median":-3.023853,"eighty":-2.081672,"marketCap":13652557},{"date":"2025-01-17","current":-0.907533,"twenty":-4.090284,"median":-3.019134,"eighty":-2.067585,"marketCap":14916119},{"date":"2025-01-24","current":-0.895816,"twenty":-4.090241,"median":-3.010309,"eighty":-2.058642,"marketCap":14723544},{"date":"2025-01-31","current":-0.750899,"twenty":-4.090241,"median":-2.997753,"eighty":-2.043977,"marketCap":12341695},{"date":"2025-02-07","current":-0.795813,"twenty":-4.088284,"median":-2.986227,"eighty":-2.027397,"marketCap":13079899},{"date":"2025-02-14","current":-0.762615,"twenty":-4.072667,"median":-2.973442,"eighty":-2.016716,"marketCap":12534270},{"date":"2025-02-21","current":-0.804343,"twenty":-4.056659,"median":-2.970335,"eighty":-2.010243,"marketCap":13220108},{"date":"2025-02-28","current":-0.729212,"twenty":-4.04696,"median":-2.964072,"eighty":-1.994631,"marketCap":11985262},{"date":"2025-03-07","current":-0.470005,"twenty":-4.046781,"median":-2.953761,"eighty":-1.988678,"marketCap":7724962},{"date":"2025-03-14","current":-0.534112,"twenty":-4.045871,"median":-2.953473,"eighty":-1.982077,"marketCap":8778614},{"date":"2025-03-21","current":-0.661755,"twenty":-4.044905,"median":-2.944364,"eighty":-1.980421,"marketCap":9332799},{"date":"2025-03-28","current":-0.638311,"twenty":-4.041261,"median":-2.937567,"eighty":-1.964134,"marketCap":9002161},{"date":"2025-04-04","current":-0.500145,"twenty":-4.03546,"median":-2.933581,"eighty":-1.951826,"marketCap":7053603},{"date":"2025-04-11","current":-0.553755,"twenty":-4.032484,"median":-2.92512,"eighty":-1.947591,"marketCap":7809661},{"date":"2025-04-17","current":-0.58267,"twenty":-4.028274,"median":-2.922007,"eighty":-1.938558,"marketCap":8217448},{"date":"2025-04-25","current":-0.632371,"twenty":-4.026282,"median":-2.909973,"eighty":-1.922833,"marketCap":8918399},{"date":"2025-05-02","current":-0.645031,"twenty":-4.026089,"median":-2.905875,"eighty":-1.915453,"marketCap":9096944},{"date":"2025-05-09","current":-0.562664,"twenty":-4.023768,"median":-2.898358,"eighty":-1.909551,"marketCap":7935303},{"date":"2025-05-16","current":-0.71839,"twenty":-4.016958,"median":-2.893258,"eighty":-1.899063,"marketCap":8530451},{"date":"2025-05-23","current":-0.73918,"twenty":-4.01329,"median":-2.887777,"eighty":-1.872577,"marketCap":8777327},{"date":"2025-05-30","current":-0.717833,"twenty":-4.008464,"median":-2.885625,"eighty":-1.86443,"marketCap":8523839},{"date":"2025-06-06","current":-0.687081,"twenty":-4.008464,"median":-2.879956,"eighty":-1.85472,"marketCap":8158684},{"date":"2025-06-13","current":-0.652772,"twenty":-4.00605,"median":-2.871746,"eighty":-1.84598,"marketCap":7751278},{"date":"2025-06-20","current":-1.423798,"twenty":-4.00415,"median":-2.862255,"eighty":-1.845009,"marketCap":16906756}],"updateTime":1750670365093}}}